PF-04523655: Clinical Trials

1 trial of PF-04523655, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow PF-04523655: new trials by email Literature Review of PF-04523655 trials Research Report on PF-04523655

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of PF-04523655 (REDD14NP) In Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (Wet AMD)
PF-04523655 - Age-Related Macular Degeneration
Phase 1CompletedQuark Pharmaceuticals542007-02-012012-10-10

Conditions studied

Choroidal Neovascularization (1)  ·  Macular Degeneration (1)

Sponsors

Quark Pharmaceuticals (1)

Countries

Israel (1)  ·  United States (1)